Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. J&J is one of the world’s most valuable companies.
Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $70.1 billion during calendar year 2015. Johnson & Johnson’s brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson’s Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.
The move by the major American stock market indices including the S&P 500 to hit their new ATHs may be fast-tracked by increased earnings reports from the companies that are going to unveil their results for the previous quarter.
The boost from the COVID vaccine sales, among other factors, has pushed Johnson & Johnson to increase its full-year earnings guidance.
The markets remained pumped up ahead of the Fed meeting on Thursday, where the central bank will discuss any stimulus tapering measures.
